Hereditary haemorrhagic telangiectasia;Maladie de Rendu-Osler-Weber

Sang Thrombose Vaisseaux

Volumn 14, Issue 8, 2002, Pages 493-499

  Perdu, Jérôme ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; RENDU OSLER WEBER DISEASE; REVIEW; TELANGIECTASIA;

EID: 0036820426     PISSN: 09997385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Rendu HJ. Épistaxis répétsées chez un sujet porteur de petits angiomes cutanés et muqueux. Gaz Hop 1896; 8: 34-51.
2. Osler W. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Bull Johns Hopkins Hosp 1901; 12: 333-7.
3. Weber FP. Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membrane associated with recurring haemorrhages. Lancet 1907; 2: 160-2.
4. Guttmacher AE, Marchuk DA, White RI, Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995; 333: 918-24.
5. Porteous ME, Burn J, Proctor SJ. Hereditary haemorrhagic telangiectasia: A clinical analysis. J Med Genet 1992; 29: 527-30.
6. Plauchu H, de Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989; 32: 291-7.
7. Shovlin CL, Hughes JM, Scott J, Seidman CE, Seidman JG. Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 1997; 61: 68-79.
8. Shovlin CL. Molecular defects in rare bleeding disorders: Hereditary haemorrhagic telangiectasia. Thromb Haemost 1997; 78: 145-50.
9. Berg JN, Guttmacher AE, Marchuk DA, Porteous ME. Clinical heterogeneity in hereditary haemorrhagic telangiectasia: Are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 1996; 33: 256-7.
10. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91: 66-7.
11. Aassar OS, Friedman CM, White RI, Jr. The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 1991; 101: 977-80.
12. Pau H, Carney AS, Murty GE. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): Otorhinolaryngological manifestations. Clin Otolaryngol 2001; 26: 93-8.
13. Sabba C, Gallitelli M, Palasciano G. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. N Engl J Med 2001; 345: 926.
14. Klepfish A, Berrebi A, Schattner A. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia. Arch Intern Med 2001; 161: 767.
15. Annichino-Bizzacchi JM, Facchini RM, Torresan MZ, Arruda VR. Hereditary hemorrhagic telangiectasia response to aminocaproic acid treatment. Thromb Res 1999; 96: 73-6.
16. Korzenik JR, Topazian MD, White R. Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med 1994; 331: 1236.
17. Saba HI, Morelli GA, Logrono LA. Brief report: Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med 1994; 330: 1789-90.
18. Phillips MD. Stopping bleeding in hereditary telangiectasia. N Engl J Med 1994; 330: 1822-3.
19. Vase P. Estrogen treatment of hereditary hemorrhagic telangiectasia: A double-blind controlled clinical trial. Acta Med Scand 1981; 209: 393-6.
20. Borsik M, Herbreteau D, Deffrennes D, et al. Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc. Ann Otolaryngol Chir Cervicofac 1992; 109: 273-6.
21. Mager JJ, Westermann CJ. Value of capillary microscopy in the diagnosis of hereditary hemorrhagic telangiectasia. Arch Dermatol 2000; 136: 732-4.
22. Morelli JG, Huff JC, Weston WL. Treatment of congenital telangiectatic vascular malformations with the pulsed-dye laser (585 nm). Pediatrics 1993; 92: 603-6.
23. Shovlin CL, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: Issues in clinical management and review of pathogenic mechanisms. Thorax 1999; 54: 714-29.
24. Haitjema T, Westermann CJ, Overtoom TT, et al. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): New insights in pathogenesis, complications, and treatment. Arch Intern Med 1996; 156: 714-9.
25. Azuma H. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia. J Med Invest 2000; 47: 81-90.
26. Maher CO, Piepgras DG, Brown RD, Jr, Friedman JA, Pollock BE. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001; 32: 877-82.
27. Shovlin CL, Winstock AR, Peters AM, Jackson JE, Hughes JM. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. QJM 1995; 88: 879-87.
28. White RI, Jr, Lynch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L, Shuman K, Kim W, Kinnison M, Mitchell SE. Pulmonary arteriovenous malformations: Techniques and long-term outcome of embolotherapy. Radiology 1988; 169: 663-9.
29. Trembath RC, Thomson JR, Machado RD, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001; 345: 325-34.
30. White RI, Jr. Pulmonary arteriovenous malformations: How do we diagnose them and why is it important to do so? Radiology 1992; 182: 633-5.
31. Fulbright RK, Chaloupka JC, Putman CM, et al. MR of hereditary hemorrhagic telangiectasia: Prevalence and spectrum of cerebrovascular malformations. Am J Neuroradiol 1998; 19: 477-84.
32. Dong SL, Reynolds SF, Steiner IP. Brain abscess in patients with hereditary hemorrhagic telangiectasia: Case report and literature review. J Emerg Med 2001; 20: 247-51.
33. Press OW, Ramsey PG. Central nervous system infections associated with hereditary hemorrhagic telangiectasia. Am J Med 1984; 77: 86-92.
34. Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 1995; 99: 519-24.
35. White RI, Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: Diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996; 7: 787-804.
36. Peery WH. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 1987; 82: 989-97.
37. Vase P, Grove O. Gastrointestinal lesions in hereditary hemorrhagic telangiectasia. Gastroenterology 1986; 91: 1079-83.
38. Kjeldsen AD, Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 2000; 95: 415-8.
39. Reilly PJ, Nostrant TT. Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 1984; 79: 363-7.
40. Halpern M, Turner AF, Citron BP. Hereditary hemorrhagic telangiectasia. An angiographic study of abdominal visceral angiodysplasias associated with gastrointestinal hemorrhage. Radiology 1968; 90: 1143-9.
41. Van Cutsem E, Brohee Prize G. Estrogenprogesterone, a new therapy of bleeding gastrointestinal vascular malformations. Acta Gastroenterol Belg 1993; 56: 2-10.
42. Hodgson H. Hormonal therapy for gastrointestinal angiodysplasia. Lancet 2002; 359: 1630-1.
43. Garcia-Tsao G, Korzenik JR, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000; 343: 931-6.
44. Bernard G, Mion F, Henry L, Plauchu H, Paliard P. Hepatic involvement in hereditary hemorrhagic telangiectasia: Clinical, radiological, and hemodynamic studies of 11 cases. Gastroenterology 1993; 105: 482-7.
45. Watanabe A. Portal-systemic encephalopathy in non-cirrhotic patients: Classification of clinical types, diagnosis and treatment. J Gastroenterol Hepatol 2000; 15: 969-79.